These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 15143160)
1. Mutations in the SAM domain of the ETV6-NTRK3 chimeric tyrosine kinase block polymerization and transformation activity. Tognon CE; Mackereth CD; Somasiri AM; McIntosh LP; Sorensen PH Mol Cell Biol; 2004 Jun; 24(11):4636-50. PubMed ID: 15143160 [TBL] [Abstract][Full Text] [Related]
2. The ETV6-NTRK3 gene fusion encodes a chimeric protein tyrosine kinase that transforms NIH3T3 cells. Wai DH; Knezevich SR; Lucas T; Jansen B; Kay RJ; Sorensen PH Oncogene; 2000 Feb; 19(7):906-15. PubMed ID: 10702799 [TBL] [Abstract][Full Text] [Related]
3. The chimeric protein tyrosine kinase ETV6-NTRK3 requires both Ras-Erk1/2 and PI3-kinase-Akt signaling for fibroblast transformation. Tognon C; Garnett M; Kenward E; Kay R; Morrison K; Sorensen PH Cancer Res; 2001 Dec; 61(24):8909-16. PubMed ID: 11751416 [TBL] [Abstract][Full Text] [Related]
4. Mutation of the salt bridge-forming residues in the ETV6-SAM domain interface blocks ETV6-NTRK3-induced cellular transformation. Cetinbas N; Huang-Hobbs H; Tognon C; Leprivier G; An J; McKinney S; Bowden M; Chow C; Gleave M; McIntosh LP; Sorensen PH J Biol Chem; 2013 Sep; 288(39):27940-50. PubMed ID: 23798677 [TBL] [Abstract][Full Text] [Related]
6. The insulin-like growth factor I receptor is required for Akt activation and suppression of anoikis in cells transformed by the ETV6-NTRK3 chimeric tyrosine kinase. Martin MJ; Melnyk N; Pollard M; Bowden M; Leong H; Podor TJ; Gleave M; Sorensen PH Mol Cell Biol; 2006 Mar; 26(5):1754-69. PubMed ID: 16478996 [TBL] [Abstract][Full Text] [Related]
7. ETV6-NTRK3: a chimeric protein tyrosine kinase with transformation activity in multiple cell lineages. Lannon CL; Sorensen PH Semin Cancer Biol; 2005 Jun; 15(3):215-23. PubMed ID: 15826836 [TBL] [Abstract][Full Text] [Related]
8. Identification of a SRC-like tyrosine kinase gene, FRK, fused with ETV6 in a patient with acute myelogenous leukemia carrying a t(6;12)(q21;p13) translocation. Hosoya N; Qiao Y; Hangaishi A; Wang L; Nannya Y; Sanada M; Kurokawa M; Chiba S; Hirai H; Ogawa S Genes Chromosomes Cancer; 2005 Mar; 42(3):269-79. PubMed ID: 15611931 [TBL] [Abstract][Full Text] [Related]
9. A highly conserved NTRK3 C-terminal sequence in the ETV6-NTRK3 oncoprotein binds the phosphotyrosine binding domain of insulin receptor substrate-1: an essential interaction for transformation. Lannon CL; Martin MJ; Tognon CE; Jin W; Kim SJ; Sorensen PH J Biol Chem; 2004 Feb; 279(8):6225-34. PubMed ID: 14668342 [TBL] [Abstract][Full Text] [Related]
10. Congenital-infantile fibrosarcoma. A clinicopathologic study of 10 cases and molecular detection of the ETV6-NTRK3 fusion transcripts using paraffin-embedded tissues. Sheng WQ; Hisaoka M; Okamoto S; Tanaka A; Meis-Kindblom JM; Kindblom LG; Ishida T; Nojima T; Hashimoto H Am J Clin Pathol; 2001 Mar; 115(3):348-55. PubMed ID: 11242790 [TBL] [Abstract][Full Text] [Related]
11. Cloning and characterization of the novel chimeric gene TEL/PTPRR in acute myelogenous leukemia with inv(12)(p13q13). Nakamura F; Nakamura Y; Maki K; Sato Y; Mitani K Cancer Res; 2005 Aug; 65(15):6612-21. PubMed ID: 16061641 [TBL] [Abstract][Full Text] [Related]
12. Cellular transformation and activation of the phosphoinositide-3-kinase-Akt cascade by the ETV6-NTRK3 chimeric tyrosine kinase requires c-Src. Jin W; Yun C; Hobbie A; Martin MJ; Sorensen PH; Kim SJ Cancer Res; 2007 Apr; 67(7):3192-200. PubMed ID: 17409427 [TBL] [Abstract][Full Text] [Related]